BDM CSD North & East

Work Schedule

Standard (Mon-Fri)

Environmental Conditions

Various outside weather conditions

Job Description

Position Summary

The Business Development Manager – CSD is responsible for driving strategic market expansion, clinical adoption, and revenue growth for Next-Generation Sequencing (NGS) & Clinical Microarray solutions in Oncology, Rare diseases & Reproductive Health segments. Based in Delhi, this role plays a critical part in expanding Thermo Fisher Scientific’s presence within the precision oncology & reproductive health ecosystem working closely with molecular pathology laboratories, cancer centers, hospitals, diagnostic networks, and reference laboratories. The position collaborates cross-functionally with sales, marketing, medical affairs, and global business teams to accelerate NGS adoption, Microarray growth and support long-term growth objectives.

Key Responsibilities

Business Development & Growth Strategy

• •Develop and execute business development strategies to expand adoption of NGS led Genomics and Microarray solutions.
• •Identify and nurture new business opportunities, strategic accounts, and clinical partnerships in oncology, RH & Rare disease diagnostics.
• •Own growth initiatives aligned to regional and national oncology, rare disease and reproductive health business objectives.
• •Drive expansion of oncology workflows across solid tumors, hematological malignancies, and translational oncology applications.

Go-to-Market & Commercial Enablement

• •Partner with commercial leadership to define and implement go-to-market strategies for genomics solutions across these segments.
• •Support new product introductions (NPIs), solution launches, and portfolio expansion initiatives.
• •Contribute to development of value propositions, pricing inputs, and proposal strategies for complex opportunities.
• •Enable sales and application teams with oncology-specific clinical messaging and positioning.

Customer & Stakeholder Engagement

• •Build and maintain strong relationships with oncologists, molecular pathologists, lab directors, and key opinion leaders (KOLs).
• •Engage major stakeholders across cancer centers, hospitals, diagnostic chains, and reference laboratories.
• •Establish and support reference sites and strategic collaborations to strengthen clinical credibility and adoption.
• •Partner with applications and medical affairs teams to support scientific discussions, clinical validation, and evidence generation.

Market Development & Insights

• •Conduct market intelligence, workflow analysis, and customer needs assessments within the Onco, RD, RH diagnostics space.
• •Track evolving precision oncology trends, Reproductive Health reimbursement landscapes, and competitive dynamics.
• •Provide structured insights and recommendations to regional and global stakeholders to inform strategy and portfolio decisions.
• •Support channel partners and commercial teams with oncology domain expertise and opportunity qualification.

Knowledge, Skills, and Abilities

• •Strong understanding of oncology genomics, NGS workflows, and molecular pathology applications.
• •Ability to translate complex scientific and clinical concepts into clear business and clinical value propositions.
• •Demonstrated strength in strategic thinking, opportunity building, and stakeholder influence.
• •Excellent communication, presentation, and negotiation skills.
• •High learning agility with a strong interest in precision oncology and personalized medicine.
• •Ability to operate effectively within a matrixed, cross-functional environment.
• •Willingness to travel as required.

Qualifications

• •Master’s or Bachelor’s degree in Life Sciences, Molecular Biology, Biotechnology, Genetics, Oncology, or a related discipline.
• •8+ years of relevant experience in business development, sales, or commercial roles within oncology diagnostics, NGS, or molecular pathology.
• •Strong, hands-on experience working in the oncology segment, preferably in NGS-based or molecular pathology solutions.
• •Proven experience engaging clinical customers, cancer centers, and diagnostic laboratories.
• •Track record of driving market expansion and strategic growth initiatives in complex clinical environments.